BCRX
Price
$8.61
Change
+$0.14 (+1.65%)
Updated
Feb 28 closing price
Capitalization
1.8B
61 days until earnings call
BEAM
Price
$26.34
Change
-$0.77 (-2.84%)
Updated
Feb 28 closing price
Capitalization
2.2B
73 days until earnings call
Ad is loading...

BCRX vs BEAM

Header iconBCRX vs BEAM Comparison
Open Charts BCRX vs BEAMBanner chart's image
BioCryst Pharmaceuticals
Price$8.61
Change+$0.14 (+1.65%)
Volume$4.23M
Capitalization1.8B
Beam Therapeutics
Price$26.34
Change-$0.77 (-2.84%)
Volume$1.47M
Capitalization2.2B
BCRX vs BEAM Comparison Chart
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCRX vs. BEAM commentary
Mar 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a StrongBuy and BEAM is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 01, 2025
Stock price -- (BCRX: $8.60 vs. BEAM: $26.33)
Brand notoriety: BCRX: Notable vs. BEAM: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 145% vs. BEAM: 114%
Market capitalization -- BCRX: $1.8B vs. BEAM: $2.2B
BCRX [@Biotechnology] is valued at $1.8B. BEAM’s [@Biotechnology] market capitalization is $2.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $402.43B to $0. The average market capitalization across the [@Biotechnology] industry is $2.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BCRX is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • BCRX’s TA Score: 4 bullish, 5 bearish.
  • BEAM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BCRX is a better buy in the short-term than BEAM.

Price Growth

BCRX (@Biotechnology) experienced а -6.62% price change this week, while BEAM (@Biotechnology) price change was -13.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.98%. For the same industry, the average monthly price growth was -6.49%, and the average quarterly price growth was -2.51%.

Reported Earning Dates

BCRX is expected to report earnings on May 01, 2025.

BEAM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-3.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.2B) has a higher market cap than BCRX($1.8B). BCRX YTD gains are higher at: 14.362 vs. BEAM (6.169). BCRX has higher annual earnings (EBITDA): -24.12M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. BCRX (330M). BEAM has less debt than BCRX: BEAM (162M) vs BCRX (809M). BCRX has higher revenues than BEAM: BCRX (413M) vs BEAM (350M).
BCRXBEAMBCRX / BEAM
Capitalization1.8B2.2B82%
EBITDA-24.12M-160.83M15%
Gain YTD14.3626.169233%
P/E RatioN/AN/A-
Revenue413M350M118%
Total Cash330M926M36%
Total Debt809M162M499%
FUNDAMENTALS RATINGS
BCRX: Fundamental Ratings
BCRX
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCRXBEAM
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 20 days ago
80%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEGIX30.51N/A
N/A
First Eagle Gold I
PMBPX44.47N/A
N/A
Principal MidCap R5
FRNRX29.20N/A
N/A
Franklin Natural Resources A
JSCSX17.20N/A
N/A
JPMorgan US Small Company I
SIPIX29.87N/A
N/A
SEI Mid-Cap I (SIMT)